Hepatitis Flashcards
What type of virus is hep A and how does it spread?
- RNA picornavirus
- faeco-oral - water (shellfish)
Prognosis and outcomes with hep A:
- typically benign, self-limiting
- serious outcome rare
- no chronic disease (so no increased risk HCC)
Who is at risk of hep A?
- Asia and Africa
- mwhswm
Incubation period of hep A:
2-4 weeks
Hep A immunisation:
- effective vaccine
- after initial dose, booster 6-12 months later
- given to: >1yo if travelling or residing in areas of prevalence, chronic liver disease, haemophilia, mwhswm, IV drug users, occupational risk
What kind of virus is hep B?
double stranded DNA hepadna virus
What is the incubation period of hep B?
6-20 weeks
How is hep B transmitted?
infected blood or bodily fluids, vertical transmission
Complications of hep B:
- chronic: ground glass hepatocytes
- fulminant liver failure
- HCC
- GN
- polyarteritis nodosa
- cryoglobulinaemia
Management of hep B:
- pegylated interferon-alpha: reduces replication increased 30% in chronic carriers
- tenofovir, entecavir, telbivudine
Hep B and pregnancy:
- screening of all pregnant women
- chronically infected/acute during pregnancy - full course of vaccines and hep B immunoglobulin
- cannot be transmitted via breastfeeding
Hep B immunisation:
- children vaccinated at 2, 3 and 4 months
- at risk groups vaccinated
- contains HBsAg absorbed onto aluminium hydroxide adjuvant prepared from yeast cells using recombinant DNA technology
- 10-15% respond poorly to 3 doses (>40yo, obesity, smoking, alcohol excess and immunosuppression)
Anti-HBs levels in response to vaccine:
> 100: indicates adequate response, booster at 5 years
10-100: suboptimal response - additional vaccine given (not if immunocompetent)
<10: non-responder - test for current or past infection, further course (3 doses)
Serology of acute hep B:
- HbsAg
- <6 mo
- also in chronic
Serology of immunity to hep B:
- anti-HBs
- post exposure or immunisation
- negative in chronic